India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Bengaluru CCB arrests Nigerian national, seizes synthetic drugs worth Rs 23.74 crore in a major crackdown. Read about the police operation and its impact.
Supreme Court permits Sandesara brothers to settle massive bank fraud case with ₹5,100 crore payment. Historic decision marks first criminal case closure after settlement. Read full details.
Supreme Court approves ₹5,100 crore settlement by fugitive Sandesara brothers in massive bank fraud case. All criminal proceedings to be dropped upon payment completion by December 2025.
Supreme Court agrees to drop criminal proceedings against Sterling Biotech promoters in bank fraud case upon payment of Rs 5,100 crore by December 17, 2025. Full case details inside.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Massive drug bust in Mizoram: Narcotics worth Rs 479 crore seized, including meth tablets and heroin. Four suspects arrested in major anti-narcotics operation. Read details.
Mumbai Police ANC summons Siddhant Kapoor, brother of Shraddha Kapoor, and influencer Orry in connection with the massive ₹252 crore MD drug seizure case. Read latest updates.
Germany's justice ministry reclassifies date rape drugs as weapons in criminal trials, strengthening prosecution of sexual assault cases. Learn how this legal change protects victims.
Indian government proposes sweeping ban on online advertisements for Schedule G, H, H1, and X drugs to combat self-medication and antimicrobial resistance. Read about the new regulatory changes.
Mumbai Police summons socialite Orry in Rs 252 crore drug case. He seeks new date citing prior commitments. Investigation continues in high-profile narcotics bust.
Social media influencer Orry faces Mumbai Police questioning in massive Rs 252 crore mephedrone drug bust case uncovered in Sangli. Latest developments.
India's biotechnology sector is projected to become a $1.2 trillion industry by 2047, driven by vaccines, diagnostics, and bio-agriculture. Discover how this growth will transform healthcare and agriculture.
A US commission warns Congress of China's growing leverage in biotech, quantum computing, and legacy semiconductors, urging action to prevent supply chain weaponization. Read the full report.
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Union Minister Bittu appeals to Himachal residents to support anti-drug campaign. Learn how communities can fight drug menace together for a safer state.
Nagaland's top police official warns drug menace could become public health emergency, calls for unified Northeast response. Golden Triangle proximity cited as major concern.
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Exclusive investigation reveals the secret journey of confiscated drugs in India's tech capital - from police vaults to scientific destruction methods that prevent environmental damage.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
In a major crackdown on drug trafficking, Assam Police intercepts huge consignment of illegal Yaba tablets in Cachar district, arresting two key suspects in coordinated operation.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Congress leader Rahul Gandhi launches scathing attack on PM Modi, comparing Instagram Reels to digital drugs and criticizing cheap data policies for creating addiction among Indian youth.
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.